DE2452691A1 - 2,6-disubstituierte phenylaminoguanidinverbindungen - Google Patents

2,6-disubstituierte phenylaminoguanidinverbindungen

Info

Publication number
DE2452691A1
DE2452691A1 DE19742452691 DE2452691A DE2452691A1 DE 2452691 A1 DE2452691 A1 DE 2452691A1 DE 19742452691 DE19742452691 DE 19742452691 DE 2452691 A DE2452691 A DE 2452691A DE 2452691 A1 DE2452691 A1 DE 2452691A1
Authority
DE
Germany
Prior art keywords
group
dichlorophenyl
hcl
alkyl
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19742452691
Other languages
German (de)
English (en)
Inventor
Harm Jan Dr Panneman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo NV
Original Assignee
Akzo NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo NV filed Critical Akzo NV
Publication of DE2452691A1 publication Critical patent/DE2452691A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/16—Compounds containing any of the groups, e.g. aminoguanidine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19742452691 1973-11-09 1974-11-06 2,6-disubstituierte phenylaminoguanidinverbindungen Withdrawn DE2452691A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7315350A NL7315350A (nl) 1973-11-09 1973-11-09 Nieuwe aminoguanidine verbindingen.

Publications (1)

Publication Number Publication Date
DE2452691A1 true DE2452691A1 (de) 1975-05-15

Family

ID=19819967

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19742452691 Withdrawn DE2452691A1 (de) 1973-11-09 1974-11-06 2,6-disubstituierte phenylaminoguanidinverbindungen

Country Status (17)

Country Link
US (1) US3972932A (enExample)
JP (1) JPS5546389B2 (enExample)
AR (1) AR205358A1 (enExample)
BE (1) BE822019A (enExample)
CA (1) CA1032962A (enExample)
CH (1) CH616656A5 (enExample)
DE (1) DE2452691A1 (enExample)
DK (1) DK138791B (enExample)
ES (1) ES431775A1 (enExample)
FI (1) FI62064C (enExample)
FR (1) FR2250521B1 (enExample)
GB (1) GB1487852A (enExample)
HU (1) HU171856B (enExample)
IE (1) IE40409B1 (enExample)
NL (1) NL7315350A (enExample)
SE (1) SE420720B (enExample)
ZA (1) ZA746701B (enExample)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4921876A (en) * 1984-09-19 1990-05-01 Ciba-Geigy Corporation Substituted carbodiimides
AT394192B (de) * 1983-12-12 1992-02-10 Biogal Gyogyszergyar Verfahren zur herstellung neuer substituierter aminoguanidin-derivate
US5403861A (en) * 1991-02-08 1995-04-04 Cambridge Neuroscience, Inc. Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers
US5559154A (en) * 1990-03-02 1996-09-24 Oregon State Board Of Higher Education Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
US5741661A (en) * 1991-02-08 1998-04-21 Cambridge Neuroscience, Inc. Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers
US5847006A (en) * 1991-02-08 1998-12-08 Cambridge Neuroscience, Inc. Therapeutic guanidines
US5922772A (en) * 1993-11-23 1999-07-13 Cambridge Neuroscience, Inc. Therapeutic substituted guanidines
US6143791A (en) * 1994-02-03 2000-11-07 Cambridge Neuroscience, Inc. Therapeutic guanidines
US6147063A (en) * 1993-05-27 2000-11-14 Cambridge Neuroscience, Inc. Therapeutic substituted guanidines
US6174924B1 (en) 1994-02-03 2001-01-16 Cambridge Neuroscience, Inc. Therapeutic guanidines
US6251948B1 (en) 1990-03-02 2001-06-26 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Tri-and tetra-substituted guanidines and their use as excitatory amino acid antagonists
US6787569B1 (en) 1994-02-03 2004-09-07 Cambridge Neuroscience, Inc. Therapeutic guanidines
US7351743B1 (en) 1994-02-03 2008-04-01 Wyeth Therapeutic guanidines

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141992A (en) * 1975-08-22 1979-02-27 American Cyanamid Company Cycloalkylcarboxyamidines and halobenzamidines as anti-amebic agents
US4113776A (en) * 1976-04-15 1978-09-12 Hoffmann-La Roche Inc. 1-(2-Aminoethyl)-3-(2,6-dihalophenyl)guanidines
ZA857153B (en) * 1984-09-19 1986-05-28 Ciba Geigy Ag Substituted carbodiimides
JP4739695B2 (ja) * 2004-06-07 2011-08-03 株式会社日本ファインケム ５−アミノ―１―置換―１，２，４―トリアゾールの製造方法、及び該製造方法で得られるトリアゾール誘導体
JP4564786B2 (ja) * 2004-06-07 2010-10-20 株式会社日本ファインケム １−置換―１―アミノグアニジン又はその塩、及びこれらの製造方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB800869A (en) * 1955-09-28 1958-09-03 Ici Ltd Substituted amino-guanidines
NL7011683A (enExample) * 1970-08-07 1972-02-09

Cited By (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT394192B (de) * 1983-12-12 1992-02-10 Biogal Gyogyszergyar Verfahren zur herstellung neuer substituierter aminoguanidin-derivate
US4921876A (en) * 1984-09-19 1990-05-01 Ciba-Geigy Corporation Substituted carbodiimides
US5637622A (en) * 1990-03-02 1997-06-10 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
US6251948B1 (en) 1990-03-02 2001-06-26 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Tri-and tetra-substituted guanidines and their use as excitatory amino acid antagonists
US5559154A (en) * 1990-03-02 1996-09-24 Oregon State Board Of Higher Education Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
US5798390A (en) * 1990-03-02 1998-08-25 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
US5767162A (en) * 1990-03-02 1998-06-16 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Tri-and tetra-substituted guanidines and their use as excitatory amino acid antagonists
US5652269A (en) * 1991-02-08 1997-07-29 Cambridge Neuroscience, Inc. Substituted hydrazinecarboximidamides and methods of use thereof
US5741661A (en) * 1991-02-08 1998-04-21 Cambridge Neuroscience, Inc. Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers
US5670519A (en) * 1991-02-08 1997-09-23 Cambridge Neuroscience, Inc. Acenaphthyl-substituted guanidines and methods of use thereof
US5672608A (en) * 1991-02-08 1997-09-30 Cambridge Neuroscience, Inc. Acenaphthyl substituted guanidines and methods of use thereof
US5677348A (en) * 1991-02-08 1997-10-14 Cambridge Neuroscience, Inc. Substituted aminoguanidines and methods of use thereof
US5681861A (en) * 1991-02-08 1997-10-28 Cambridge Neuroscience, Inc. Aminoguanidines and methods of use of same
US5686495A (en) * 1991-02-08 1997-11-11 Cambridge Neuroscience, Inc. Substituted hydrazinedicarboximidamides and methods of use thereof
US6071969A (en) * 1991-02-08 2000-06-06 Cambridge Neuroscience, Inc. Substituted aminoguanidines and methods of use thereof
US5622968A (en) * 1991-02-08 1997-04-22 Cambridge Neuroscience, Inc. Acenaphthyl substituted guanidines and methods of use thereof
US5614630A (en) * 1991-02-08 1997-03-25 Cambridge Neuroscience, Inc. Acenaphthyl substituted guanidines and methods of use thereof
US5837737A (en) * 1991-02-08 1998-11-17 Cambridge Neuroscience, Inc. Hydrazinedicarboximidamide compounds and pharmaceutical composition comprising same
US5847006A (en) * 1991-02-08 1998-12-08 Cambridge Neuroscience, Inc. Therapeutic guanidines
US5403861A (en) * 1991-02-08 1995-04-04 Cambridge Neuroscience, Inc. Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers
US5637623A (en) * 1991-02-08 1997-06-10 Cambridge Neuroscience, Inc. Substituted adamantyl guanidines and methods of use there of
US6153604A (en) * 1993-05-27 2000-11-28 Cambridge Neuroscience, Inc. Therapeutic substituted guanidines
US6147063A (en) * 1993-05-27 2000-11-14 Cambridge Neuroscience, Inc. Therapeutic substituted guanidines
US5955507A (en) * 1993-11-23 1999-09-21 Cambridge Neuroscience, Inc. Therapeutic substituted guanidines
US6013675A (en) * 1993-11-23 2000-01-11 Cambridge Neuroscience, Inc. Therapeutic substituted guanidines
US6156741A (en) * 1993-11-23 2000-12-05 Cambridge Neuroscience, Inc. Therapeutic substituted guanidines
US5922772A (en) * 1993-11-23 1999-07-13 Cambridge Neuroscience, Inc. Therapeutic substituted guanidines
US6143791A (en) * 1994-02-03 2000-11-07 Cambridge Neuroscience, Inc. Therapeutic guanidines
US6174924B1 (en) 1994-02-03 2001-01-16 Cambridge Neuroscience, Inc. Therapeutic guanidines
US6288123B1 (en) 1994-02-03 2001-09-11 Cambridge Neurosciences, Inc. Therapeutic guanidines
US6787569B1 (en) 1994-02-03 2004-09-07 Cambridge Neuroscience, Inc. Therapeutic guanidines
US7351743B1 (en) 1994-02-03 2008-04-01 Wyeth Therapeutic guanidines

Also Published As

Publication number Publication date
JPS5077328A (enExample) 1975-06-24
IE40409L (en) 1975-05-09
ES431775A1 (es) 1976-12-16
FI62064C (fi) 1982-11-10
JPS5546389B2 (enExample) 1980-11-22
HU171856B (hu) 1978-04-28
FR2250521A1 (enExample) 1975-06-06
BE822019A (fr) 1975-05-09
AR205358A1 (es) 1976-04-30
DK138791B (da) 1978-10-30
CA1032962A (en) 1978-06-13
SE7414045L (enExample) 1975-05-12
ZA746701B (en) 1975-11-26
FI62064B (fi) 1982-07-30
DK138791C (enExample) 1979-04-09
GB1487852A (en) 1977-10-05
CH616656A5 (enExample) 1980-04-15
FR2250521B1 (enExample) 1979-03-16
NL7315350A (nl) 1975-05-13
US3972932A (en) 1976-08-03
DK579774A (enExample) 1975-07-07
IE40409B1 (en) 1979-05-23
SE420720B (sv) 1981-10-26
FI324374A7 (enExample) 1975-05-10

Similar Documents

Publication Publication Date Title
DE2452691A1 (de) 2,6-disubstituierte phenylaminoguanidinverbindungen
DE1518778A1 (de) Verfahren zur Herstellung von neuen Guanidinoderivaten von Polyalkylenpolyaminen
DE2139526A1 (enExample)
DE1802394A1 (de) Aminoguanidine,Verfahren zu ihrer Herstellung und ihre Verwendung
DE1620501A1 (de) Neue Sydnonimin-Derivate und Verfahren zu ihrer Herstellung
DE2129960C2 (de) Thioureidoderivate enthaltende therapeutische Zusammensetzungen, Verfahren zu deren Herstellung sowie die Thioureidoderivate
DE1915230B2 (de) Hydroxyphenylalkylaminderivate, verfahren zu deren herstellung und arzneimittel auf deren basis
CH643821A5 (de) Substituierte phenylacetylguanidine, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
CH507277A (de) Verfahren zur Herstellung neuer substituierter 3-Amino-sydnonimine
EP0004529B1 (de) Tantomere Arylaminoimidazolinderivate, deren Herstellung und sie enthaltende Arzneimittel zur Bekämpfung von Schmerzzuständen
DE2356239A1 (de) Benzophenon-derivate und verfahren zu ihrer herstellung
DE1912941B2 (de) 1 -PhenyM-amino-e-methoxypridaziniumsalze
DE2640616C3 (de) Verfahren zur Herstellung von N-Acyl-2-aiylglycinen
DE2426977A1 (de) N,n'-disubstituierte amidine und verfahren zu ihrer herstellung
DE1939738A1 (de) Aminoguanidine und Verfahren zur Herstellung derselben
DE1960026A1 (de) Neue Derivate des 3-Amino-1,2-benzisothiazols und ein Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE1695580C (de) Quaternare Verbindungen des Benzil saure beta piperidino athylesters und ein Verfahren zu ihrer Herstellung
DE1545844A1 (de) Verfahren zur Herstellung von N-substituierten 3-Aminobenzisothiazolen
DE1545844C (de) 3 Amino benzisothiazole und Verfah ren zu deren Hersteilung
AT326101B (de) Verfahren zur herstellung von neuen substituierten formylazapentadiennitrilen sowie von deren säureadditionssalzen
AT232500B (de) Verfahren zur Herstellung von neuen Phenylalaninderivaten
DE1695695C3 (de) Verfahren zur Herstellung von 2-Aminofuro eckige Klammer auf 2,3-d eckige Klammer zu thiazolen
AT350538B (de) Verfahren zur herstellung von neuen substi- tuierten 3,3'-triphenyl-methan-dicarbonsaeuren und von deren salzen
AT345852B (de) Verfahren zur herstellung neuer furylharnstoffe
DE2515548A1 (de) Quaternaere ammoniumsalze von n-dialkylaminoalkyl-n-(2-indanyl)-anilinen und verfahren zu ihrer herstellung

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8130 Withdrawal